TerminatedNot applicableNCT03966807

Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members

The purpose of this pilot study is to examine, in an innovative setting, the potential for a lung cancer diagnosis in a loved one to represent a teachable moment for smoking cessation in family members or caregivers who are current smokers. The researchers will identify the willingness and preferred modality for smoking cessation among family members/caregivers in this setting. The researchers will estimate abstinence rates at 4, 8, 12, and 24 weeks..

Checked against the public recordLast updated Jan 18, 2024 · Source: ClinicalTrials.gov

StatusTerminated
PhaseNot applicable
U.S. locations1
SponsorIndiana University
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Indiana University
Interventions being studied
Behavioral: Digital-based support; Behavioral: Traditional-based support + Nicotine replacement therapy (NRT)
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Patient Inclusion Criteria: 1. patient with newly diagnosed lung cancer within the last 6 months of initial diagnosis/confirmation of diagnosis at the study sites 2. Able to provide informed consent 3. Able to speak and read English Family Member/Caregiver Participant Criteria: 1. Family member or caregiver (defined as first degree relative \[parent, sibling, child\] or person living in the same household) 2. Family member or caregiver must be a current, active smoker (defined as 10 cigarettes per day for 6 consecutive months). 3. At least 18 years of age at time of study consent 4. Able to provide informed consent 5. Able to speak and read English Exclusion Criteria: 1. Currently receiving formal tobacco dependence treatment- Nicotine replacement of any kind, varenicycline or Bupropion. 2. Medical condition that precludes proposed pharmacotherapy for smoking cessation : Recent (≤ 2 weeks) myocardial infarction , history of underlying arrhythmias , history of serious or worsening angina pectoris, pregnancy and breastfeeding

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Indiana University Melvin & Bren Simon Cancer CenterIndianapolis, Indiana

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 18, 2024. Always confirm current availability with the study team.

View original record ↗